Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -40.70x is 68% below its 4-year average of -24.28x, around the middle of its 4-year range (-74.78x–-8.12x).
As of the fiscal period ended Monday, September 30, 2024. 46.78% below its 12-month average of -27.73x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2024 (2024-09-30): -40.70x.
INTEREST COVERAGE RATIO
-40.70x
INTEREST COVERAGE RATIO AVG TTM
-27.73x
INTEREST COVERAGE RATIO AVG 3Y
-20.36x
INTEREST COVERAGE RATIO AVG 5Y
-24.28x
INTEREST COVERAGE RATIO AVG 10Y
-52.24x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-46.78%
CURRENT VS 3Y AVG
-99.85%
CURRENT VS 5Y AVG
-67.61%
CURRENT VS 10Y AVG
+22.09%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.68x
median of 460 covered companies
CURRENT VS SECTOR MEDIAN
-616.47%
vs the sector median at left
Corbus Pharmaceuticals Holdings, Inc.
Market Cap
$107.65M
Interest Coverage Ratio
-40.70x
TTM Avg
-27.73x
3Y Avg
-20.36x
5Y Avg
-24.28x
Market Cap
$108.59M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$109.37M
Interest Coverage Ratio
-236.86x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$110.11M
Interest Coverage Ratio
-280.53x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$105.01M
Interest Coverage Ratio
-1.82x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.68M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$110.75M
Interest Coverage Ratio
-1.15x
TTM Avg
4.51x
3Y Avg
6.93x
5Y Avg
222.11x
Market Cap
$105.87M
Interest Coverage Ratio
-5.63x
TTM Avg
53.06x
3Y Avg
67.81x
5Y Avg
43.09x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | $107.65M | -40.70x | -27.73x | -20.36x | -24.28x |
| Immunic, Inc. (IMUX)vs › | $108.82M | N/A | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.59M | N/A | N/A | N/A | N/A |
| Outlook Therapeutics, Inc. (OTLK)vs › | $109.37M | -236.86x | N/A | N/A | N/A |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $110.11M | -280.53x | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $105.01M | -1.82x | N/A | N/A | N/A |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | N/A | N/A | N/A | N/A |
| Apyx Medical Corporation (APYX)vs › | $110.75M | -1.15x | 4.51x | 6.93x | 222.11x |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $105.87M | -5.63x | 53.06x | 67.81x | 43.09x |
| BGM Group Ltd. (BGM)vs › | $116.34M | N/A | 30.61x | 29.12x | 24.09x |
Interest Coverage
-40.7x
Debt/Equity
0.04
Current Ratio
5.71
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-09-30 | -40.70x |
| 2024-06-30 | -16.85x |
| 2024-03-31 | -54.36x |
| 2023-12-31 | -14.29x |
| 2023-09-30 | -12.43x |
| 2023-06-30 | -8.12x |
| 2023-03-31 | -25.51x |
| 2022-12-31 | -16.84x |
| 2022-09-30 | -15.10x |
| 2022-06-30 | -14.97x |
| 2022-03-31 | -18.56x |
| 2021-12-31 | -25.58x |
| 2021-09-30 | -35.41x |
| 2021-06-30 | -41.63x |
| 2021-03-31 | -23.84x |
| 2020-09-30 | -74.78x |
| 2016-03-31 | -449.02x |
| 2015-12-31 | -2341.55x |
| 2015-06-30 | -6520.85x |
| 2015-03-31 | -1568.23x |
| 2014-12-31 | -1289.99x |
| 2014-09-30 | -1258.77x |
| 2014-06-30 | -41.34x |
| 2014-03-31 | -9.46x |
| 2013-12-31 | -19.99x |
| 2013-09-30 | -4.84x |
